Evidence map›Paper›PMID 29018022›Full record

Trial reportJournal of the American Heart Association2017

Higher Adiposity Is Associated With Slower Cognitive Decline in Hypertensive Patients: Secondary Analysis of the China Stroke Primary Prevention Trial.

Jun Zhang, Genfu Tang, Haiqun Xie, Binyan Wang, Mingli He, Jia Fu, Xiuli Shi, Chengguo Zhang, Yong Huo, Xiping Xu and 1 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00794885 (Enalapril Maleate and Folic Acid Tablets for Primary Prevention of Stroke in Patients With Hypertension), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00794885 phase4completednot on this map

Enalapril Maleate and Folic Acid Tablets for Primary Prevention of Stroke in Patients With Hypertension: a Post-marketing, Double-blind, Randomized Controlled Trial.

TypeinterventionalSponsorShenzhen Ausa Pharmed Co.,LtdRan2008 to 2014Enrolled20,702ConditionsPrimary HypertensionArmsEnalapril/folic acid, Enalapril maleate
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Jun ZhangDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Genfu TangInstitute for Biomedicine, Anhui Medical University, Hefei, China.
Haiqun XieDepartment of Neurology, The Affiliated Foshan Hospital of Sun Yat-sen University, Foshan, China.
Binyan WangInstitute for Biomedicine, Anhui Medical University, Hefei, China.
Mingli HeDepartment of Neurology, The First People's Hospital of Lianyungang, Lianyungang, China.
Jia FuDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xiuli ShiDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Chengguo ZhangDepartment of Neurology, The Affiliated Foshan Hospital of Sun Yat-sen University, Foshan, China.
Yong HuoDepartment of Cardiology, Peking University First Hospital, Beijing, China.
Xiping XuInstitute for Biomedicine, Anhui Medical University, Hefei, China.
Kai WangDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China wangkai1964@126.com.
Anhui Medical University · CNAnhui Mental Health Center · CNFoshan Hospital of TCM · CNNanfang Hospital · CNPeking University · CNSouthern Medical University · CNSun Yat-sen University · CNThe First People’s Hospital of Lianyungang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity is a risk factor for many diseases. However, the potential association between adiposity and cognitive decline in hypertensive patients is inconclusive. We performed a secondary data analysis of the CSPPT (China Stroke Primary Prevention Trial) to examine whether adiposity is correlated with longitudinal cognitive performance in hypertensive adults. METHODS AND

resultsThe analysis included 16 791 patients in the CSPPT who received at least 2 cognitive assessments by the Mini-Mental State Examination (MMSE) during the follow-up (median, 4.5 years; interquartile range, 4.2-4.8 years). Outcomes included changes in MMSE scores and cognitive impairment (defined as MMSE score less than education-specific cutoff point). A marked reduction in MMSE scores at the final (compared with at the 1-year) follow-up was apparent in both men (n=4838; mean [SD] score, 0.41 [3.62]) and women (n=7190; mean [SD] score, 1.07 [4.61]; both

conclusionsHigher adiposity is independently associated with slower cognitive decline in Chinese hypertensive adults. CLINICAL

trial registrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT00794885 CSPPT.

Indexed as

AdiposityBlood PressureCognitionAgedAntihypertensive AgentsBody Mass IndexChinaChi-Square DistributionCognition DisordersFemaleHumansHypertensionLinear ModelsLongitudinal StudiesMaleMental Status and Dementia TestsAntihypertensive Agentsadipositybody mass indexcognitive declinehypertensionwaist circumference

Identifiers

PMID29018022
PMCPMC5721823
OpenAlexW2762440282

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.